← Back to Search

Gastrointestinal Bleeding Peripheral Pulse Volume for Gastrointestinal Bleeding

N/A
Waitlist Available
Led By Andrew Storm, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- Adults (age \>18yr) undergoing emergent endoscopy for active GI bleeding.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, approximately 2 hours post endoscopy
Awards & highlights
No Placebo-Only Group

Summary

The purpose and aim of this study are to compare changes in pulse volume to non-invasively predict active bleeding or high-risk stigmata in patients undergoing a gastrointestinal endoscopy to assess feasibility of the flow meter clinically.

Eligible Conditions
  • Gastrointestinal Bleeding

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, approximately 2 hours post endoscopy
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, approximately 2 hours post endoscopy for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in peripheral pulse volume with and without active bleeding

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gastrointestinal Bleeding Peripheral Pulse VolumeExperimental Treatment1 Intervention
Subject undergoing an emergency endoscopic evaluation for active gastrointestinal bleeding will have their peripheral pulse volumes monitored using a pulse flowmeter throughout the procedure and 2 hours after the procedure.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,333 Previous Clinical Trials
3,060,162 Total Patients Enrolled
Andrew Storm, MDPrincipal InvestigatorMayo Clinic
1 Previous Clinical Trials
206 Total Patients Enrolled
~0 spots leftby Dec 2024